
Keywords: Pancreatic Cancer; Marker; T-cell Activation; Cytokine Production; dMMR; DNA mismatch repair; ICK; immune checkpoint; IHC; immunohistochemistry; IPMN; intraductal papillary mucinous neoplasm; MMR; mismatch repair; MSI; microsatellite instability; PCR; po